Incidence and survival characteristics of pediatric ganglioglioma from 2004 to 2018, with focus on infratentorial sites

IF 2.4 Q2 CLINICAL NEUROLOGY Neuro-oncology practice Pub Date : 2024-02-09 DOI:10.1093/nop/npae012
Yongzhen Chen, Paula Buchanan, N. Brossier, P. Navalkele
{"title":"Incidence and survival characteristics of pediatric ganglioglioma from 2004 to 2018, with focus on infratentorial sites","authors":"Yongzhen Chen, Paula Buchanan, N. Brossier, P. Navalkele","doi":"10.1093/nop/npae012","DOIUrl":null,"url":null,"abstract":"\n \n \n Ganglioglioma (GG) is a slow-growing glioneuronal neoplasm, most frequently seen in the supratentorial location in older children and associated with epilepsy syndromes. GG is rare in the infratentorial location, hence we embarked upon analyzing the National Cancer Institute’s (NCI) Survival, Epidemiology, and End Results (SEER) database to better evaluate GG outcomes by location in comparison to the broader pediatric low-grade glioma (pLGG) population.\n \n \n \n Pediatric patients diagnosed with GG and pLGG from 2004 to 2018 were included in the study. Their demographic, clinical and survival characteristics were analyzed using SEER*Stat.\n \n \n \n This study describes the largest cohort of pediatric GG, including 852 cases from year 2004 to 2018, with focus on infratentorial sites. Patients with brainstem GG or those with subtotally resected disease were identified as having higher risk of death.\n \n \n \n Our analysis highlights brainstem GG as a high-risk, poor-prognostic subgroup and elaborates on the incidence and survival characteristic of this lesser-known subgroup.\n","PeriodicalId":19234,"journal":{"name":"Neuro-oncology practice","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-oncology practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npae012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Ganglioglioma (GG) is a slow-growing glioneuronal neoplasm, most frequently seen in the supratentorial location in older children and associated with epilepsy syndromes. GG is rare in the infratentorial location, hence we embarked upon analyzing the National Cancer Institute’s (NCI) Survival, Epidemiology, and End Results (SEER) database to better evaluate GG outcomes by location in comparison to the broader pediatric low-grade glioma (pLGG) population. Pediatric patients diagnosed with GG and pLGG from 2004 to 2018 were included in the study. Their demographic, clinical and survival characteristics were analyzed using SEER*Stat. This study describes the largest cohort of pediatric GG, including 852 cases from year 2004 to 2018, with focus on infratentorial sites. Patients with brainstem GG or those with subtotally resected disease were identified as having higher risk of death. Our analysis highlights brainstem GG as a high-risk, poor-prognostic subgroup and elaborates on the incidence and survival characteristic of this lesser-known subgroup.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2004年至2018年小儿神经节胶质瘤的发病率和存活特征,重点关注幕下部位
神经节胶质细胞瘤(GG)是一种生长缓慢的神经胶质细胞瘤,最常见于年长儿童的脑室上位,并与癫痫综合征有关。因此,我们开始分析美国国家癌症研究所(NCI)的生存、流行病学和最终结果(SEER)数据库,以便更好地评估GG与更广泛的儿科低级别胶质瘤(pLGG)人群相比在不同部位的预后。 研究纳入了2004年至2018年期间诊断为GG和pLGG的儿科患者。研究人员使用 SEER*Stat 对这些患者的人口统计学、临床和生存特征进行了分析。 这项研究描述了最大规模的儿科GG队列,包括2004年至2018年的852例病例,重点关注脑干下部位。脑干GG患者或次全切除的患者死亡风险较高。 我们的分析强调了脑干GG是一个高风险、预后差的亚组,并阐述了这个鲜为人知的亚组的发病率和生存特征。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neuro-oncology practice
Neuro-oncology practice CLINICAL NEUROLOGY-
CiteScore
5.30
自引率
11.10%
发文量
92
期刊介绍: Neuro-Oncology Practice focuses on the clinical aspects of the subspecialty for practicing clinicians and healthcare specialists from a variety of disciplines including physicians, nurses, physical/occupational therapists, neuropsychologists, and palliative care specialists, who have focused their careers on clinical patient care and who want to apply the latest treatment advances to their practice. These include: Applying new trial results to improve standards of patient care Translating scientific advances such as tumor molecular profiling and advanced imaging into clinical treatment decision making and personalized brain tumor therapies Raising awareness of basic, translational and clinical research in areas of symptom management, survivorship, neurocognitive function, end of life issues and caregiving
期刊最新文献
European Association of Neuro-Oncology’s 30th anniversary: A successful and growing relationship with Neuro-Oncology Practice European Association of Neuro-Oncology’s 30th anniversary: A successful and growing relationship with Neuro-Oncology Practice Clinical outcomes for pleomorphic xanthoastrocytoma patients Financial Toxicity of Oral Chemotherapy in Patients with Primary Brain Tumors Socioeconomic driven disparities in neuro-oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1